Federal autism advisory board cancels first public meetin...

What’s Happening

So basically A federal advisory committee on autism issues has canceled plans for its first public meeting since new members were appointed earlier this year.

Politics Politics Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency By Lizzy Lawrence Pharmalot Pharmalot STAT Plus: Novo Nordisks Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds By Ed Silverman Pharmalot Pharmalot STAT Plus: Up and down the ladder: The latest comings and goings By Ed Silverman Adams Take Adams Take STAT Plus: The FDA, urged to avoid controversy, creates a new headache with attack against UniQure By Adam Feuerstein The Readout The Readout STAT Plus: Modernas reset hinges on oncology By Meghana Keshavan STAT Plus: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says By Adam Feuerstein STAT Plus: A new mystery emerges about Epsteins involvement in Harvard genetics study By Megan Molteni STAT Plus: How can HHS drive clinical AI adoption? (we’re not making this up)

Why This Matters

Medical professionals are taking note of this development.

This is the kind of health news that affects everyday decisions.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

How do you feel about this development?